Chemiluminescence activity of phagocytes from tracheal aspirates of premature infants after surfactant therapy

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 6, 1996, Pages 719-723

  Schrod, L ^a,b   Hornemann, F ^a   Von Stockhausen, H B ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC PEPTIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LUMINOL; LUNG SURFACTANT; OPSONIN; ZYMOSAN;

ARTICLE; ARTIFICIAL VENTILATION; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; MACROPHAGE; MALE; NEWBORN; PHAGOCYTE; PHAGOCYTOSIS; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY BURST; RESPIRATORY DISTRESS SYNDROME; TRACHEOBRONCHIAL TREE;

EID: 0029787043     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14133.x     Document Type: Article

References (28)

1. Egberts J, Sprengers BM, Sietaram MA. Comparison of the pulmonary surfactant content in alveolar macrophages of newborn, young, and adult rats. Exp Lung Res 1992;18:274-85
2. Hallman M, Merritt TA, Pohjavuori M, Gluck E. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and relationship to severity of respiratory failure. Pediatr Res 1986;20:1228-35
3. Ikegami M, Adams FH, Towers B, Osher B. The quantity of natural surfactant necessary to prevent the respiratory distress syndrome in premature lambs. Pediatr Res 1980;14:1082-5
4. Disse B, Weller E, Lützen L, Ziegler H, Eberhardt H. Comparison between natural and artificial surfactant preparations in premature rabbit fetuses. In: Lachmann B, editor. Surfactant replacement therapy. Berlin: Springer, 1989:42-46
5. Richman PS, Batcher C, Cantazaro A. Pulmonary surfactant suppresses the immune lung injury response to inhaled antigen in guinea pigs. J Lab Clin Med 1990;116:18-26
6. Hayakawa H, Giridhar G, Myrvik QN, Kucer L. Pulmonary surfactant phospholipids modulate priming of rabbit alveolar macrophages for oxidative responses. J Leukoc Biol 1992;51: 379-85
7. Wilsher ML, Parker DJ, Haslam PL. Immunosuppression by the pulmonary surfactant: mechanisms of action. Thorax 1990;45:3-8
8. Golde DW, Territo M, Finley TN, Cline MJ. Defective lung macrophages in pulmonary alveolar proteinosis. Ann Int Med 1976;85:304-9
9. Kurland G, Cheung ATW, Miller ME, Ayin SA, Cho MM, Ford EW. The ontogeny of pulmonary defenses: alveolar macrophage function in neonatal and juvenile rhesus monkeys. Pediatr Res 1988;23:293-7
10. Sherman M, Goldstein E, Lippert W, Wennberg R. Neonatal lung defense mechnisms: a study of the alveolar macrophage system in neonatal rabbits. Am Rev Respir Dis 1977;116:433-40
11. La Force FM, Kelley WJ, Huber GL. Inactivation of staphylococci by alveolar macropahges with preliminary observations on the importance of alveolar lining material. Am Rev Respir Dis 1973;108:783-90
12. Juers JA, Rogers RM, Mc Curdy JB, Cook WW. Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material. J Clin Invest 1976;58:271-5
13. Webb DSA, Jeska EL. Enhanced luminol-dependent chemiliminescene of stimulated rat alveolar macrophages by pretreatment with alveolar lining material. J Leukocyte Biol 1986;40:55-64
14. Coonrod DJ, Jarrells MC, Yoneda K. Effect of rat surfactant lipids on complement and Fc receptors of macrophages. Infect Immun 1986;54:371-8
15. Speer CP, Götze B, Curstedt T, Robertson B. Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf). Pediatr Res 1991;30:69-74
16. Sherman MP, D'Ambola JB, Aeberhard EE, Barrett CT. Surfactant therapy of newborn rabbits impairs lung macrophage bactericidal activity. J Appl Physiol 1988;65:137-45
17. van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, van Golde LMG. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990;2:91-8
18. Ansfield MJ, Benson BJ. Identification of the immunosuppressive components of canine pulmonary surface active material. J Immunol 1980;125:1093-8
19. Mosser DM. Receptors on phagocytic cells involved in microbial recognition. Immunol Serol 1990;60:99-114
20. Baggiolini M, Boulay F, Badwey JA, Curnutte JT. Activation of neutrophil leukocytes: chemoattractant receptors and respiratory burst. FASEB 1993;7:1004-10
21. Allen RC. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol 1986;133:449-93
22. Commins LM, Loegering DJ, Gudewicz PW. Effect of phagocytosis of erythrocytes and erythrocyte ghosts on macrophage phyagocytic function and hydrogen peroxide production. Inflammation 1990;14:705-12
23. Stewart LS, Leceaga J, Brock JH. Inhibition of hydrogen peroxide release from activated macrophages by prior ingestion of erythrocytes or haemoglobin. FEMS Microbiol Immunol 1988;1:27
24. Geertsma MF, Broos HR, van der Barselaar MT, Nibbering PH, van Furth R. Lung surfactant suppresses oxygen-dependent bactericidal functions of human blood monocytes by inhibiting the assembly of the NADPH oxidase. J Immunol 1993;150:2391-400
25. Hallman M, Epstein BL, Gluck L. Analysis of labelling and clearance of lung surfactant phospholipids in rabbits. J Clin Invest 1981;68:742-51
26. Gräbner R, Meerbach W. Phagocytosis of surfactant by alveolar macrophages in vitro. Am J Physiol 1991;261:L472-7
27. Ogushi K, Ikegami H, Jobe A. Clearance of large amounts of natural surfactants and liposomes of dipalmitoylphosphatidylcholine from the lungs of rabbits. Exp Lung Res 1985;9:221-37
28. Jacob J, Edwards D, Gluck L. Early-onset sepsis and pneumonia observed in respiratory distress syndrome. Am J Dis Child 1980;134:766-8